PEG Biosciences Inc (PBI) is a biotechnology company based in Monmouth Junction, New Jersey, specializing in the development of innovative therapeutics targeted to unmet medical needs. With a focus on novel drug delivery technology, PBI aims to create first-in-class and best-in-class drugs for the treatment of diseases such as cancer, infectious diseases, and autoimmune disorders.
Led by Dr. Chyi Lee, a renowned expert in the development of Pegylated drugs, PBI's proprietary BioSynersys and ProbioTherapeutic technologies offer advanced drug delivery solutions that can be leveraged by pharmaceutical and biotechnology partners to realize the full potential of their products. With a dedicated team committed to creating breakthrough medicines, PBI is at the forefront of developing innovative therapies to address critical medical challenges.
Generated from the website